NCT03066466 2021-04-27Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMTLoyola UniversityPhase 3 Withdrawn
NCT00002790 2015-03-06Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow TransplantFred Hutchinson Cancer CenterPhase 1/2 Withdrawn
NCT00081055 2014-12-04OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic MalignanciesMesoblast, Ltd.Phase 2 Withdrawn
NCT00301912 2012-10-02Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerUniversity of California, San FranciscoPhase 2 Withdrawn